Metsera, Inc. - MTSR

SEC FilingsOur MTSR Tweets

About Gravity Analytica

Recent News

  • 09.29.2025 - Metsera Reports Positive Phase 2b Results for First- and Best-in-Class Ultra-long Acting GLP-1 RA Candidate MET-097i, Enabling Rapid Transition into Phase 3
  • 09.29.2025 - Metsera Reports Positive Phase 2b Results for First- and Best-in-Class Ultra-long Acting GLP-1 RA Candidate MET-097i, Enabling Rapid Transition into Phase 3
  • 09.22.2025 - Pfizer to Acquire Metsera and its Next-Generation Obesity Portfolio
  • 09.22.2025 - Pfizer to Acquire Metsera and its Next-Generation Obesity Portfolio
  • 09.11.2025 - Metsera to Present Research Highlighting its Next-Generation Obesity Portfolio at the 61st EASD Annual Meeting
  • 09.11.2025 - Metsera to Present Research Highlighting its Next-Generation Obesity Portfolio at the 61st EASD Annual Meeting
  • 09.04.2025 - September 4, 2025 4:30 PM EDT - September 4, 2025 5:05 PM EDT : Wells Fargo 2025 Healthcare Conference
  • 09.04.2025 - September 4, 2025 4:30 PM EDT - September 4, 2025 5:05 PM EDT : Wells Fargo 2025 Healthcare Conference
  • 09.03.2025 - September 3, 2025 3:20 PM EDT - September 3, 2025 3:50 PM EDT : Cantor Global Healthcare Conference 2025
  • 09.03.2025 - September 3, 2025 3:20 PM EDT - September 3, 2025 3:50 PM EDT : Cantor Global Healthcare Conference 2025

Recent Filings

  • 09.29.2025 - EX-99.1 EX-99.1
  • 09.29.2025 - 8-K Current report
  • 09.22.2025 - 8-K Current report
  • 09.22.2025 - EX-99.1 EX-99.1
  • 09.12.2025 - 4/A Statement of changes in beneficial ownership of securities
  • 09.04.2025 - 4 Statement of changes in beneficial ownership of securities